Identification of peptide sequences that target to the brain using in vivo phage display

Amino Acids

Volumn 42, Issue 6, 2012, Pages 2373-2381

  Li, Jingwei ^a,b   Zhang, Qizhi ^a,b   Pang, Zhiqing ^a,b   Wang, Yuchen ^a,b   Liu, Qingfeng ^a,b   Guo, Liangran ^a,b   Jiang, Xinguo ^a,b  

^a FUDAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Blood brain barrier (BBB); Brain targeting; Peptide; Phage display

Indexed keywords

CYCLOPEPTIDE; PEPTIDE; PEPTIDE 7; PEPTIDE C7; PEPTIDE SC7; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIOPHAGE M13; BRAIN TISSUE; CIRCULATION TIME; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISULFIDE BOND; DRUG DELIVERY SYSTEM; DRUG TARGETING; IMAGE ANALYSIS; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE LIBRARY; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN TRANSPORT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

ANIMALS; BACTERIOPHAGE M13; BLOOD-BRAIN BARRIER; BRAIN; CARBOCYANINES; CLONE CELLS; DRUG DELIVERY SYSTEMS; FLUORESCENT ANTIBODY TECHNIQUE; FLUORESCENT DYES; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED ICR; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES, CYCLIC; SEQUENCE ANALYSIS, DNA;

MUS;

EID: 84862770544     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-0979-y     Document Type: Article

References (43)

1. NJ Abbott 2005 Physiology of the blood-brain barrier and its consequences for drug transport to the brain Int Congr 1277 3 18 10.1016/j.ics.2005.02.008 1:CAS:528:DC%2BD1cXhvVOhtb4%3D
2. NJ Abbott AAK Patabendige DEM Dolman, et al. 2010 Structure and function of the blood-brain barrier Neurobiol Dis 37 13 25 19664713 10.1016/j.nbd.2009. 07.030 1:CAS:528:DC%2BD1MXhsVGms73P
3. W Arap R Pasqualini E Ruoslahti 1988 Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 279 377 380 10.1126/science.279.5349.377
4. W Arap W Haedicke M Bernasconi, et al. 2002 Targeting the prostate for destruction through a vascular address Proc Natl Acad Sci 99 1527 1531 11830668 10.1073/pnas.241655998 1:CAS:528:DC%2BD38Xht1ClsbY%3D
5. Barbas CF, Burton DR, Scott JK, Silverman GJ (2001) Phage Display: A laboratory manual. Cold Spring Harbor Laboratory Press, New York, pp 1.1-1.37
6. MA Barry WJ Dower SA Johnston 1996 Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries Nat Med 2 299 305 8612228 10.1038/nm0396-299 1:CAS:528: DyaK28XhsVGkt78%3D
7. A Béduneau P Saulnier JP Benoit 2007 Active targeting of brain tumors using nanocarriers Biomaterials 28 4947 4967 17716726 10.1016/j.biomaterials.2007.06.011
8. DJ Begley 2004 Delivery of therapeutic agents to the central nervous system: the problems and the possibilities Pharmacol Ther 104 29 45 15500907 10.1016/j.pharmthera.2004.08.001 1:CAS:528:DC%2BD2cXovVKqsrc%3D
9. S Cabilly 1999 The basic structure of filamentous phage and its use in the display of combinatorial peptide libraries Mol Biotechnol 12 143 148 10596371 10.1385/MB:12:2:143 1:CAS:528:DyaK1MXnsFSltbg%3D
10. PM Cardarelli S Yamagata I Taguchi, et al. 1992 The collagen receptor-alpha-2-beta-1, from MG-63 and HT1080-cells, interacts with a cyclic RGD peptide J Biol Chem 267 23159 23164 1331077 1:CAS:528:DyaK38XlvV2jsLo%3D
11. L Costantino G Tosi B Ruozi, et al. 2009 Colloidal systems for CNS drug delivery Prog Brain Res 180 35 69 20302828 10.1016/S0079-6123(08)80003-9 1:CAS:528:DC%2BC3cXht1Wrsbg%3D
12. M Demeule A Regina C Che, et al. 2008 Identification and design of peptides as a new drug delivery system for the brain Pharmacol Exp Ther 324 1064 1072 10.1124/jpet.107.131318 1:CAS:528:DC%2BD1cXivVajsL0%3D
13. R Gabathuler 2010 Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases Neurobiol Dis 37 48 57 19664710 10.1016/j.nbd.2009.07.028 1:CAS:528:DC%2BD1MXhsVGms7jE
14. KL Hu JW Li YH Shen, et al. 2009 Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluations J Control Rel 134 55 61 10.1016/j.jconrel.2008.10.016 1:CAS:528: DC%2BD1MXhsFelt7s%3D
15. J Huwyler D Wu WM Pardridge 1996 Brain drug delivery of small molecules using immunoliposomes Proc Natl Acad Sci 93 14164 14169 8943078 10.1073/pnas.93.24.14164 1:CAS:528:DyaK28Xnt1GrsLo%3D
16. JA Joyce P Laakkonen M Bernasconi, et al. 2003 Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis Cancer Cell 4 393 401 14667506 10.1016/S1535-6108(03)00271-X 1:CAS:528:DC%2BD3sXps1Ojtro%3D
17. JW Kehoe BK Kay 2005 Filamentous phage display in the new millennium Chem Rev 105 4056 4072 16277371 10.1021/cr000261r 1:CAS:528:DC%2BD2MXhtFalu7zF
18. 1 integrin from a phage display library J Cell Biol 124 373 380 7507494 10.1083/jcb.124.3.373 1:CAS:528:DyaK2cXpvFKgsA%3D%3D
19. MG Kolonin J Sun KA Do, et al. 2006 Synchronous selection of homing peptides for multiple tissues by in vivo phage display FASEB J 20 E99 E107 10.1096/fj.05-5186fje
20. JH Lee JA Engler JF Collawn BA Moore 2001 Receptor mediated uptake of peptides that bind the human transferrin receptor Eur J Biochem 268 2004 2012 11277922 10.1046/j.1432-1327.2001.02073.x 1:CAS:528:DC%2BD3MXivVarsrc%3D
21. TY Lee HC Wu YL Tseng CT Lin 2004 A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery Cancer Res 64 8002 8008 15520208 10.1158/0008-5472.CAN-04-1948 1:CAS:528:DC%2BD2cXptFels7k%3D
22. X Liu C Chen 2005 Strategies to optimize brain penetration in drug discovery Curr Opin Drug Disc 8 505 512 1:CAS:528:DC%2BD2MXlvFCgtLo%3D
23. KK Murai LN Nguyen M Koolpe, et al. 2003 Targeting the EphA4 receptor in the nervous system with biologically active peptides Mol Cell Neurosci 24 1000 1011 14697664 10.1016/j.mcn.2003.08.006 1:CAS:528:DC%2BD3sXpvFymtr0%3D
24. SA Nicklin SJ White SJ Watkins, et al. 2000 Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display Circulation 102 231 237 10889136 1:CAS:528:DC%2BD3cXltlOisLY%3D
25. J Pande MM Szewczyk AK Grover 2010 Phage display: concept, innovations and future Biotechnol Adv 28 849 858 20659548 10.1016/j.biotechadv.2010.07.004 1:CAS:528:DC%2BC3cXht1WltrzI
26. WM Pardridge 2005 Molecular biology of the blood-brain barrier Mol Biotechnol 30 57 70 15805577 10.1385/MB:30:1:057 1:CAS:528:DC%2BD2MXktlyltrs%3D
27. R Pasqualini E Ruoslahti 1996 Organ targeting in vivo using phage display peptide libraries Nature 380 364 366 8598934 10.1038/380364a0 1:CAS:528:DyaK28XhvFyrtLw%3D
28. R Pasqualini E Koivunen E Ruoslahti 1997 Integrins as receptors for tumor targeting by circulating ligands Nat Biotechnol 15 542 546 9181576 10.1038/nbt0697-542 1:CAS:528:DyaK2sXjslSqsrg%3D
29. R Pasqualini E Koivunen R Kain, et al. 2000 Aminopeptidease N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis Cancer Res 60 722 727 10676659 1:CAS:528:DC%2BD3cXht1Gmtbc%3D
30. B Praveen B Alex N Maiken 2004 The blood-brain barrier: an overview: structure, regulation and clinical implications Neurobiol Dis 16 1 13 10.1016/j.nbd.2003.12.016
31. D Rajotte W Arap M Hagedorn, et al. 1998 Molecular heterogeneity of the endothelium revealed by in vivo phage display J Clin Invest 102 430 437 9664085 10.1172/JCI3008 1:CAS:528:DyaK1cXkslOktLg%3D
32. Re F, Cambianica I, Zona C et al (2011) Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model. Nanomed Nanotech biol Med (in Press)
33. A Régina M Demeule C Ché, et al. 2008 Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2 Brit J Pharmacol 155 185 197 10.1038/bjp.2008.260
34. C Roney P Kulkarni V Arora, et al. 2005 Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease J Control Rel 108 193 214 10.1016/j.jconrel.2005.07.024 1:CAS:528:DC%2BD2MXht1aiu7vK
35. IV Rooy SC Tascioglu PO Couraud, et al. 2010 Identification of peptide ligands for targeting to the blood-brain barrier Pharm Res 27 673 682 20162339 10.1007/s11095-010-0053-6
36. E Ruoslahti MD Pierschbacher 1987 New perspectives in cell-adhesion-RGD and integrins Science 238 491 497 2821619 10.1126/science.2821619 1:CAS:528:DyaL1cXntVKkuw%3D%3D
37. SS Sidhu 2001 Engineering M13 for phage display Biomol Eng 18 57 63 11535417 10.1016/S1389-0344(01)00087-9 1:CAS:528:DC%2BD3MXnvF2js7s%3D
38. GP Smith 1985 Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface Science 228 1315 1317 4001944 10.1126/science.4001944 1:STN:280:DyaL2M3hvVOquw%3D%3D
39. GP Smith VA Petrenko 1997 Phage Display Chem Rev 97 391 410 11848876 10.1021/cr960065d 1:CAS:528:DyaK2sXhslamtb8%3D
40. K Ulbrich T Hekmatara E Herbert J Kreutre 2009 Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB) Eur J Parm Biopharm 71 251 256 10.1016/j.ejpb.2008.08.021 1:CAS:528:DC%2BD1MXitVShsb4%3D
41. XM Wan YP Chen WR Xu, et al. 2009 Identification of nose-to-brain homing peptide through phage display Peptides 30 343 350 19007831 10.1016/j.peptides. 2008.09.026 1:CAS:528:DC%2BD1MXosVWjsg%3D%3D
42. Y Zhang WM Pardridge 2005 Delivery of β-galactosidase to mouse brain via the blood-brain barrier transferrin receptor J Pharmaco Exp Ther 313 1075 1108 10.1124/jpet.104.082974 1:CAS:528:DC%2BD2MXkslekt7s%3D
43. J Zou MT Dickerson NK Owen, et al. 2004 Biodistribution of filamentous phage peptide libraries in mice Mol Biol Rep 31 121 129 15293788 10.1023/B:MOLE.0000031459.14448.af 1:CAS:528:DC%2BD2cXkslWqtbk%3D